益生菌膳食补充剂市场－全球产业规模、份额、趋势、机会与预测，按形式、最终用途、应用、地区和竞争细分，2020-2030 年

2024 年全球益生菌膳食补充剂市场价值为 87.6 亿美元，预计在预测期内实现强劲增长，到 2030 年年复合成长率(CAGR) 为 10.75%。

由于消费者行为明显转向科学验证和积极主动的健康管理方法，市场正在经历加速扩张。益生菌——经临床证明对肠道和免疫健康有益的活性微生物菌株——正在成为广泛消费者群体中循证营养策略的一个组成部分。

这种日益增长的采用与生活方式相关的健康状况的日益流行密切相关，包括胃肠道疾病、免疫反应减弱和慢性发炎 - 特别是在成年人和老年人群中。消费者越来越倾向于天然、非药物的替代品，从而刺激了对符合清洁标籤原则和预防性保健实践的益生菌产品的需求。

关键市场驱动因素

胃肠道疾病和生活方式相关疾病盛行率上升

主要市场挑战

品质控制和产品标准化

主要市场趋势

个人化营养的出现

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球益生菌膳食补充剂市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按剂型（咀嚼片和软糖、胶囊、粉末、片剂和软胶囊、其他）
  • 依最终用途（婴儿、儿童、成人、老年人）
  • 按应用（运动健身、能量与体重管理、一般健康、骨骼与关节健康、胃肠道健康、免疫力、心臟健康、糖尿病、抗癌、皮肤/头髮/指甲、大脑/心理健康、其他）
  • 按地区
  • 按公司分类（2024）
• 产品市场图

第六章：北美益生菌膳食补充剂市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲益生菌膳食补充剂市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙

第八章：亚太益生菌膳食补充剂市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国

第九章：南美洲益生菌膳食补充剂市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲益生菌膳食补充剂市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 科威特

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Vitakem Nutraceutical Inc
• Lesaffre International Corp
• DuPont de Nemours Inc
• H&H Group PLC
• Amway Corp
• Abbott Laboratories Inc
• Bayer AG
• Pfizer Inc.
• GSK PLC
• BASF SE

第 15 章：策略建议

第16章调查会社について・免责事项

The Global Probiotics Dietary Supplements Market was valued at USD 8.76 billion in 2024 and is projected to achieve strong growth over the forecast period, with a compound annual growth rate (CAGR) of 10.75% through 2030.

The market is experiencing accelerated expansion, driven by a clear shift in consumer behavior toward scientifically validated and proactive approaches to health management. Probiotics-live microbial strains with clinically proven benefits for gut and immune health-are becoming an integral component of evidence-based nutritional strategies across a broad range of consumer demographics.

This growing adoption is closely tied to the increasing prevalence of lifestyle-related health conditions, including gastrointestinal disorders, weakened immune response, and chronic inflammation-particularly among adults and aging populations. Consumers are gravitating toward natural, non-pharmaceutical alternatives, fueling demand for probiotic products that align with clean-label principles and preventive wellness practices.

Key Market Drivers

Rising Prevalence of Gastrointestinal and Lifestyle-Related Disorders

The surge in gastrointestinal (GI) and lifestyle-related disorders is a key growth driver for the probiotics dietary supplements market. Non-communicable diseases (NCDs), which include many of these disorders, have become the dominant global health challenge, accounting for approximately 75% of all non-pandemic-related deaths. In 2021, NCDs were responsible for over 43 million deaths worldwide, with cardiovascular conditions leading the count.

This shift has influenced both consumer behavior and healthcare priorities, positioning probiotics as an essential element of preventive and therapeutic strategies focused on gut health and overall well-being. Digestive issues such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), acid reflux, constipation, and bloating are increasingly common across various age groups and geographies, further driving demand for probiotic supplementation.

Key Market Challenges

Quality Control and Product Standardization

Maintaining the quality, efficacy, and stability of probiotic supplements remains a significant challenge. As live microorganisms, probiotics must remain viable throughout the entire production, packaging, storage, and distribution cycle. Any degradation in potency can result in inconsistent health outcomes and potentially undermine consumer confidence. Ensuring stringent quality standards and formulation integrity is therefore critical for sustained market growth and credibility.

Key Market Trends

Emergence of Personalized Nutrition

The growing demand for individualized health solutions is reshaping the probiotics landscape. Personalized nutrition-including custom probiotic formulations-is gaining momentum as consumers increasingly seek products tailored to their unique physiological needs. Innovations such as DNA testing and microbiome analysis are enabling the identification of specific probiotic strains that deliver targeted benefits based on individual health profiles, paving the way for highly personalized and effective wellness interventions.

Key Market Players

• Vitakem Nutraceutical Inc
• Lesaffre International Corp
• DuPont de Nemours Inc
• H&H Group PLC
• Amway Corp
• Abbott Laboratories Inc
• Bayer AG
• Pfizer Inc.
• GSK PLC
• BASF SE

Report Scope:

In this report, the Global Probiotics Dietary Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Probiotics Dietary Supplements Market, By Form:

• Chewables & Gummies
• Capsules
• Powders
• Tablets & Softgels
• Others

Probiotics Dietary Supplements Market, By End-Use:

• Infants
• Children
• Adults
• Geriatric

Probiotics Dietary Supplements Market, By Application:

• Sports Fitness
• Energy & Weight Management
• General Health
• Bone & Joint Health
• Gastrointestinal Health
• Immunity
• Cardiac Health
• Diabetes
• Anti-cancer
• Skin/Hair/Nails
• Brain/Mental Health
• Others

Probiotics Dietary Supplements Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Probiotics Dietary Supplements Market.

Available Customizations:

Global Probiotics Dietary Supplements market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Probiotics Dietary Supplements Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 5.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 5.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map

6. North America Probiotics Dietary Supplements Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 6.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 6.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Probiotics Dietary Supplements Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Form
      • 6.3.1.2.2. By End-use
      • 6.3.1.2.3. By Applications
  • 6.3.2. Canada Probiotics Dietary Supplements Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Form
      • 6.3.2.2.2. By End-use
      • 6.3.2.2.3. By Applications
  • 6.3.3. Mexico Probiotics Dietary Supplements Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Form
      • 6.3.3.2.2. By End-use
      • 6.3.3.2.3. By Applications

7. Europe Probiotics Dietary Supplements Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 7.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 7.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Probiotics Dietary Supplements Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Form
      • 7.3.1.2.2. By End-use
      • 7.3.1.2.3. By Applications
  • 7.3.2. United Kingdom Probiotics Dietary Supplements Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Form
      • 7.3.2.2.2. By End-use
      • 7.3.2.2.3. By Applications
  • 7.3.3. France Probiotics Dietary Supplements Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Form
      • 7.3.3.2.2. By End-use
      • 7.3.3.2.3. By Applications
  • 7.3.4. Italy Probiotics Dietary Supplements Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Form
      • 7.3.4.2.2. By End-use
      • 7.3.4.2.3. By Applications
  • 7.3.5. Spain Probiotics Dietary Supplements Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Form
      • 7.3.5.2.2. By End-use
      • 7.3.5.2.3. By Applications

8. Asia-Pacific Probiotics Dietary Supplements Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 8.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 8.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Probiotics Dietary Supplements Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Form
      • 8.3.1.2.2. By End-use
      • 8.3.1.2.3. By Applications
  • 8.3.2. Japan Probiotics Dietary Supplements Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Form
      • 8.3.2.2.2. By End-use
      • 8.3.2.2.3. By Applications
  • 8.3.3. India Probiotics Dietary Supplements Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Form
      • 8.3.3.2.2. By End-use
      • 8.3.3.2.3. By Applications
  • 8.3.4. Australia Probiotics Dietary Supplements Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Form
      • 8.3.4.2.2. By End-use
      • 8.3.4.2.3. By Applications
  • 8.3.5. South Korea Probiotics Dietary Supplements Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Form
      • 8.3.5.2.2. By End-use
      • 8.3.5.2.3. By Applications

9. South America Probiotics Dietary Supplements Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 9.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 9.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Probiotics Dietary Supplements Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Form
      • 9.3.1.2.2. By End-use
      • 9.3.1.2.3. By Applications
  • 9.3.2. Argentina Probiotics Dietary Supplements Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Form
      • 9.3.2.2.2. By End-use
      • 9.3.2.2.3. By Applications
  • 9.3.3. Colombia Probiotics Dietary Supplements Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Form
      • 9.3.3.2.2. By End-use
      • 9.3.3.2.3. By Applications

10. Middle East and Africa Probiotics Dietary Supplements Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 10.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 10.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Probiotics Dietary Supplements Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Form
      • 10.3.1.2.2. By End-use
      • 10.3.1.2.3. By Applications
  • 10.3.2. Saudi Arabia Probiotics Dietary Supplements Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Form
      • 10.3.2.2.2. By End-use
      • 10.3.2.2.3. By Applications
  • 10.3.3. UAE Probiotics Dietary Supplements Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Form
      • 10.3.3.2.2. By End-use
      • 10.3.3.2.3. By Applications
  • 10.3.4. Kuwait Probiotics Dietary Supplements Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Form
      • 10.3.4.2.2. By End-use
      • 10.3.4.2.3. By Applications

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Vitakem Nutraceutical Inc
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Lesaffre International Corp
• 14.3. DuPont de Nemours Inc
• 14.4. H&H Group PLC
• 14.5. Amway Corp
• 14.6. Abbott Laboratories Inc
• 14.7. Bayer AG
• 14.8. Pfizer Inc.
• 14.9. GSK PLC
• 14.10. BASF SE

15. Strategic Recommendations

16. About Us & Disclaimer